U.S. Pharma Stock News

NYSE:NFG
NYSE:NFGGas Utilities

A Look At National Fuel Gas (NFG) Valuation After Its New US$1.3b Credit Facility Agreement

National Fuel Gas (NFG) has updated its financing toolkit by entering an Amended and Restated Credit Agreement that provides a US$1.3 billion unsecured revolving credit facility, extending liquidity coverage for routine needs and potential acquisitions. See our latest analysis for National Fuel Gas. That expanded credit facility arrives at a time when momentum in National Fuel Gas’s shares has been firm, with a 90-day share price return of 21.26% and a 1-year total shareholder return of...
NYSE:NRG
NYSE:NRGElectric Utilities

NRG Energy (NRG) Is Up 6.0% After Doubling Fleet With LS Power Deal And Data Center Push

NRG Energy recently expanded its contracted data center power capacity to about 445 megawatts and closed the LS Power portfolio acquisition, roughly doubling its generation fleet to around 25 gigawatts while updating its 2026 financial guidance. These moves deepen NRG’s role in supplying power to AI and data center customers, while adding a commercial virtual power plant platform that could reshape how it monetizes flexible generation and grid services. We’ll now examine how the LS Power...
NasdaqCM:ONCY
NasdaqCM:ONCYBiotechs

Is Oncolytics Biotech (ONCY) Price Reset Creating A Long Term Opportunity?

Wondering if Oncolytics Biotech at US$1.04 is priced for its potential or already running ahead of itself? This article walks through what the numbers are actually saying about value. The stock shows mixed return figures, with a 7 day return of 8.3%, 30 day return of 2.0%, year to date return of 5.7%, a 1 year return of 108.0%, a 3 year return of 11.9% decline, and a 5 year return of 64.5% decline that some investors may see as a reset in expectations. Recent attention around Oncolytics...
NasdaqGS:BBIO
NasdaqGS:BBIOBiotechs

BridgeBio Pharma Data Updates Shift Focus To Rare Disease Pipeline Potential

BridgeBio Pharma (NasdaqGS:BBIO) reported long term data for acoramidis (Attruby) in transthyretin amyloid cardiomyopathy, showing sustained efficacy, safety and quality of life outcomes over several years. The company highlighted the role of early and continuous treatment for ATTR-CM patients, citing ongoing unmet medical needs with existing options. BridgeBio submitted a New Drug Application to the US FDA for BBP-418, supported by Phase 3 data in limb-girdle muscular dystrophy type...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

Merit Medical Weighs Growth Potential Of View Point Deal And Medtronic Tie-Up

Merit Medical Systems (NasdaqGS:MMSI) has acquired View Point Medical, expanding its presence in interventional medical devices. The company has also broadened its distribution agreement with Medtronic, widening access to Merit's products through Medtronic's channels. For investors watching NasdaqGS:MMSI, these moves come as the stock trades around $68.65, with a mixed return profile over recent periods. Shares show an 11.9% return over 5 years, alongside weaker performance over the past 1,...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

Why CoreWeave (CRWV) Is Up 11.9% After $21 Billion Long-Term Meta AI Cloud Deal And What's Next

On 9 April 2026, CoreWeave announced an expanded long-term agreement to supply Meta with AI cloud capacity through December 2032, worth about US$21.00 billion and including early deployments of NVIDIA’s Vera Rubin platform across multiple locations. This multi-year commitment deepens CoreWeave’s role as critical infrastructure for Meta’s AI ambitions while further diversifying its large-scale cloud customer base. We’ll now examine how this expanded Meta agreement, and its long-term revenue...
NYSE:YOU
NYSE:YOUSoftware

Clear Secure (YOU) Valuation Check After FedRAMP Milestone Puts Future Government Business In Focus

FedRAMP milestone puts Clear Secure in focus Clear Secure (YOU) is drawing fresh investor attention after its CLEAR1 platform received a FedRAMP "In Process" designation at the Moderate level, a key milestone for working with federal agencies. See our latest analysis for Clear Secure. While the FedRAMP news has put Clear Secure back on the radar, the share price tells its own story, with a 30 day share price return of 6.78% and a 90 day share price return of 34.37%, feeding into a 1 year...
NYSE:LOW
NYSE:LOWSpecialty Retail

A Look At Lowe’s (LOW) Valuation After Recent Retail Strength And Analyst Upgrades

Lowe's Companies (LOW) has been in focus after recent retail sales data and analyst upgrades coincided with a move higher in the share price, drawing fresh attention to the home improvement retailer. See our latest analysis for Lowe's Companies. The recent 7-day share price return of 7.26% and 1-day move of 1.70% suggest momentum has picked up again. This comes even though the 90-day share price return of 7.26% and 30-day share price return of 1.31% declines point to a softer patch over the...
NYSE:RS
NYSE:RSMetals and Mining

Do Governance Pushback and Rising Geopolitical Costs Recast Reliance’s (RS) Risk-Reward Profile?

In early April 2026, Reliance, Inc. urged shareholders via a definitive proxy filing to vote against an investor proposal that would require any director failing to secure a future majority vote in an uncontested election to leave the board within nine months, ahead of its May 20, 2026 annual meeting. At the same time, Reliance has been contending with geopolitical disruptions around the Israel-US-Iran conflict that are affecting operations through higher freight and insurance costs and...
NasdaqGM:DJT
NasdaqGM:DJTInteractive Media and Services

How Investors Are Reacting To Trump Media (DJT) Pivoting From Truth Social Toward Fintech And Fusion

In recent weeks, Trump Media & Technology Group has reportedly considered spinning off its Truth Social business while shifting toward fintech, cryptocurrencies, digital assets, and a nuclear fusion venture via a proposed merger with TAE Technologies and Texas Ventures III. This potential reconfiguration would move the company beyond its original social media roots, raising questions about how investors assess a business model spanning online communication, financial technology, and advanced...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Does Comcast’s Expanded StreamSaver Aggregation Strategy Reshape Its Broadband-Centric Investment Narrative (CMCSA)?

Earlier this month, Comcast’s Xfinity expanded its StreamSaver bundles to include Disney+, Hulu, HBO Max, Netflix, Apple TV, and Peacock, while also enhancing its StreamStore platform to simplify how customers mix, match, and manage multiple streaming subscriptions on a single bill. By positioning itself as a central hub for premium streaming services, Comcast is leaning further into aggregation, aiming to deepen customer engagement across its broadband and entertainment ecosystem. We’ll now...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Assessing Omnicell (OMCL) Valuation After Recent Share Price Volatility

Omnicell (OMCL) has been on investors’ radar after recent trading left the shares with a one-month return of about a 9% decline and a past three-month move of roughly a 30% decline. See our latest analysis for Omnicell. At a share price of US$35.47, Omnicell’s 7 day share price return of 3.9% contrasts with a 30 day share price return of about a 9% decline and a year to date share price return of about a 21% decline. The 1 year total shareholder return of 14.1% shows the effect of holding...
NasdaqGS:STRA
NasdaqGS:STRAConsumer Services

Assessing Strategic Education (STRA) Valuation After Recent Share Price Moves And Education Technology Growth Narrative

Recent performance snapshot for Strategic Education Strategic Education (STRA) has drawn investor attention after recent share price moves, with the stock closing at US$82.46 and showing mixed returns over the past month and past 3 months. See our latest analysis for Strategic Education. For context, the recent 3.7% 1 month share price return comes after a modest 4.9% year to date share price gain and a 1 year total shareholder return of 8.0%. The 3 year total shareholder return remains...
NYSE:SR
NYSE:SRGas Utilities

Spire’s $800 Million Loan Reshapes Nashville Growth And Debt Profile

Spire (NYSE:SR) has secured an $800 million senior unsecured term loan. The financing is intended to fund the acquisition of Piedmont Natural Gas Company's Nashville operations. The transaction represents a significant expansion of Spire's footprint in the Nashville, Tennessee area. Spire, trading at $95.19 per share, is moving ahead with one of its larger corporate moves in recent years by financing a sizeable acquisition in Nashville. The stock has returned 14.4% year to date and 32.7%...
NYSE:CMI
NYSE:CMIMachinery

Is Cummins (CMI) Balancing Data Center Ambitions With Evolving Expectations on Governance and Oversight?

On April 2, 2026, Cummins Inc. filed its definitive proxy statement, urging shareholders to vote against two shareholder proposals on evaluating the risks of its charitable contributions and separating the Board Chair and CEO roles ahead of the May 12, 2026 annual meeting. The pushback against these governance and disclosure proposals highlights ongoing tension between Cummins’ current leadership structure, its approach to corporate responsibility, and a subset of activist investors seeking...
NYSE:MSI
NYSE:MSICommunications

How Satellite-Enabled APX NEXT Radios and Mission-Critical AI At Motorola Solutions (MSI) Have Changed Its Investment Story

In early April 2026, T-Mobile announced a collaboration with Motorola Solutions to add T-Priority and Starlink-powered T-Satellite connectivity to Motorola’s APX NEXT smart radios, extending resilient, multi-network communications for first responders across land mobile radio, 5G, Wi‑Fi and low earth orbit satellite coverage. Around the same time, Motorola Solutions moved to deepen its mission-critical AI capabilities by acquiring HyperYou, aiming to use agentic AI to better interpret 911...
NYSE:GNRC
NYSE:GNRCElectrical

Assessing Generac Holdings (GNRC) Valuation After New CPower Energy Partnership

Generac Holdings (GNRC) is back in focus after announcing a partnership with CPower Energy to deploy distributed energy solutions such as battery storage, generators and microgrids across the PJM electricity market. See our latest analysis for Generac Holdings. The new CPower agreement comes after a period of strong share price momentum, with a 90-day share price return of 35.71% and a year-to-date share price return of 46.95%. The 1-year total shareholder return sits at 91.26%, despite a...
NYSE:JOBY
NYSE:JOBYAirlines

Is Joby’s AI-Enabled Airspace Strategy Reshaping The Investment Case For Joby Aviation (JOBY)?

In recent months, Joby Aviation and Air Space Intelligence announced a partnership to apply ASI’s Flyways AI platform to Joby’s eVTOL operations, while Joby was also selected for the White House-backed eVTOL Integration Pilot Program that permits early air taxi services across multiple U.S. states before full FAA type certification. Together, these steps position Joby at the center of how electric air taxis may be managed and integrated into U.S. airspace, potentially shaping future...
NYSE:COP
NYSE:COPOil and Gas

Ceasefire Reframes ConocoPhillips Qatar LNG Disruption And Valuation Upside

War in Iran has disrupted global oil supply routes and damaged energy infrastructure, including LNG projects connected to ConocoPhillips’ Qatar operations. ConocoPhillips, ticker NYSE:COP, faces delays and logistical challenges across parts of its LNG supply chain as a result of the conflict. A ceasefire agreement between the U.S. and Iran is expected to ease some supply constraints and reduce pressure on oil prices, shifting conditions for LNG project execution. For ConocoPhillips at a...
NYSE:BSX
NYSE:BSXMedical Equipment

Clinical Wins and Legal Strains Might Change The Case For Investing In Boston Scientific (BSX)

In late March 2026, Boston Scientific reported a series of medical device milestones, including FDA 510(k) clearance for its Asurys Fluid Management System and strong clinical trial results for its WATCHMAN FLX and EKOS systems across urology, atrial fibrillation and pulmonary embolism care. At the same time, the company has been hit by multiple securities class action lawsuits over allegedly misleading statements about its U.S. Electrophysiology segment, creating a contrast between clinical...
NYSE:HXL
NYSE:HXLAerospace & Defense

A Look At Hexcel (HXL) Valuation After The Commercial Aerospace Rally Following Cease-Fire News

Why Hexcel’s stock is moving now Hexcel (HXL) is trading in the slipstream of a broader commercial aerospace rally, as investors respond to renewed optimism after President Donald Trump’s cease-fire announcement and reassess exposure to the sector. At the same time, Hexcel has refreshed its financing arrangements by entering a new US$750 million revolving credit facility and drawing US$300 million to refinance its prior agreement. This may matter for investors focused on balance sheet...
NYSE:VSH
NYSE:VSHElectronic

Is It Too Late To Consider Vishay Intertechnology (VSH) After Its 91% One-Year Surge?

If you are wondering whether Vishay Intertechnology at around US$21.33 is still offering value after a strong run, you are not alone. The stock has posted returns of 14.8% over the last week, 23.2% over the last month, 39.5% year to date and 91.2% over the past year. This naturally raises questions about what is already priced in and how much risk you are now taking. Recent coverage has focused on Vishay Intertechnology's position within the broader electronics space and how investors are...
NasdaqGS:QS
NasdaqGS:QSAuto Components

What QuantumScape (QS)'s Shift to Licensing and New Advisory Hire Means For Shareholders

QuantumScape Corporation recently announced that Dr. Mark Maybury, a senior Lockheed Martin technology leader with deep commercialization and AI expertise, joined its strategic advisory board, alongside confirmation that its solid-state battery business is pivoting toward a licensing-focused model supported by partners such as Volkswagen’s PowerCo. This combination of an experienced commercialization advisor and a move toward a capital-light licensing approach could meaningfully influence...
NYSE:MNSO
NYSE:MNSOMultiline Retail

How Investors Are Reacting To MINISO Group Holding (MNSO) Rising Sales, Weaker Earnings and Bigger Dividends

MINISO Group Holding Limited reported fourth-quarter 2025 results showing higher sales of CNY 6,254.07 million but a net loss of CNY 141.52 million, while for the full year sales rose to CNY 21,443.83 million alongside lower net income of CNY 1,205.05 million, and it completed a HK$ 632.51 million repurchase of 19,003,004 shares representing 6.17% of its share base. Despite weaker profitability and higher impairment losses in 2025, the company increased shareholder payouts with a US$ 0.0941...